The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects

Journal of Human Hypertension

Volumn 29, Issue 12, 2015, Pages 737-743

  Williamson, P M ^a   Ong, S L H ^a,b   Whitworth, J A ^c   Kelly, J J ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE ACETATE; ISOSORBIDE MONONITRATE; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; ANTIINFLAMMATORY AGENT; DELAYED RELEASE FORMULATION; HYDROCORTISONE; ISOSORBIDE DINITRATE; NITRIC ACID DERIVATIVE; NITRIC OXIDE DONOR;

ADULT; ARTICLE; BLOOD EXAMINATION; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELEVATED BLOOD PRESSURE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MERCURY SPHYGMOMANOMETER; METABOLIC PARAMETERS; NORMAL HUMAN; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TONOMETRY; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE MONITORING; CHEMICALLY INDUCED; DELAYED RELEASE FORMULATION; DRUG EFFECTS; YOUNG ADULT;

ADULT; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY WEIGHT; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; HEALTHY VOLUNTEERS; HUMANS; HYDROCORTISONE; HYPERTENSION; ISOSORBIDE DINITRATE; MALE; NITRATES; NITRIC OXIDE DONORS; NITRITES; YOUNG ADULT;

EID: 84947045406     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2015.14     Document Type: Article

References (35)

1. Kelly JJ, Mangos G, Williamson PM, Whitworth JA. Cortisol and hypertension. Clin Exp Pharmacol Physiol Suppl 1998; 25: S51-S56.
2. Whitworth JA, Gordon D, Andrews J, Scoggins BA. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens 1989; 7(7): 537-549.
3. Williamson PM, Kelly JJ, Whitworth JA. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens 1996; 14(Suppl 5): S37-S41.
4. Sudhir K, Jennings GL, Esler MD, Korner PI, Blomberg PA, Lambert GW, et al. Hydrocortisone-induced hypertension in man. Pressor responsiveness and sympathetic function. Hypertension 1989; 13: 416.
5. Tam SH, Kelly JJ, Williamson PM, Whitworth JA. Reflex sympathetic function in cortisol-induced hypertension in humans. Clin Exp Hypertens 1997; 19(4): 479-493.
6. Whitworth JA, Williamson PM, Brown MA, Morris MJ. Neuropeptide Y in cortisolinduced hypertension in male volunteers. Clin Exp Pharmacol Physiol 1994; 21(5): 435-438.
7. Williamson PM, Tam SH, Kelly JJ, Whitworth JA. Ganglion blockade does not prevent cortisol-induced hypertension in man. Clin Exp Pharmacol Physiol 2005; 32(4): 294-296.
8. Pirpiris M, Yeung S, Dewar E, Jennings GL, Whitworth JA. Hydrocortisone-induced hypertension in men. The role of cardiac output. Am J Hypertens 1993; 6(4): 287-294.
9. Whitworth JA, Williamson PM, Ramsay D. Haemodynamic responses to cortisol in man: Effects of felodipine. Hypertens Res 1994; 1994(17): 134-172.
10. Tam SH, Williamson PM, Kelly JJ, Whitworth JA. Autonomic blockade amplifies cortisol-induced hypertension in man. Clin Exp Pharmacol Physiol 1997; 24(1): 31-33.
11. Kelly JJ, Tam SH, Williamson PM, Lawson J, Whitworth JA. The nitric oxide system and cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 1998; 25 (11): 945-946.
12. Ong SLH, Whitworth JA. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol Metab Clin North Am 2011; 40(2): 393-407.
13. Ong SLH, Whitworth JA. Glucocorticoid-induced hypertension and the nitric oxide system. Expert Rev Endocrinol Metab 2012; 7(3): 273-280.
14. Kelly JJ, Tam SH, Williamson PM, Whitworth JA. Decreased threshold for the nitric oxide donor glyceryl trinitrate in cortisol-induced hypertension in humans. Clin Exp Pharmacol Physiol 2007; 34(12): 1317-1318.
15. Lou Y, Wen C, Li M, Adams DJ, Wang M, Yang F, et al. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension 2001; 37(4): 1164-1170.
16. Ong SLH, Zhang Y, Whitworth JA. Reactive oxygen species and glucocorticoidinduced hypertension. Clin Exp Pharmacol Physiol 2008; 35(4): 477-482.
17. Kelly JJ, Williamson P, Martin A, Whitworth JA. Effects of oral L-Arginine on plasma nitrate and blood pressure in cortisol-Dreated humans. J Hypertens 2001; 19(2): 263-268.
18. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens 2000; 13 (11): 1155-1160.
19. Macefield VG, Williamson PM, Wilson LR, Kelly JJ, Gandevia SC, Whitworth JA. Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans. Blood Press 1998; 7(4): 215-222.
20. Nyberg G. Current status of isosorbide-5-mononitrate therapy in chronic stable angina pectoris. Am J Ther 1994; 1(1): 93-101.
21. Andrews MC, Schyvens CG, Zhang Y, McKenzie KU, Whitworth JA. Nitric oxide donation lowers blood pressure in adrenocorticotrophic hormone-induced hypertensive rats. Clin Exp Hypertens 2004; 26(6): 499-509.
22. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and aii inhibition on pulse wave reflection in hypertension. Hypertension 2003; 41(2): 297-301.
23. O'Rourke MF, Seward JB. Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov. Mayo Clin Proc 2006; 81(8): 1057-1068.
24. Mangos GJ, Turner SW, Fraser TB, Whitworth JA. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. J Hypertens 2000; 18(12): 1849-1855.
25. Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. L-Arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Press 2000; 9(5): 298-304.
26. Turner SW, Wen C, Li M, Whitworth JA. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996; 27(2): 184-189.
27. Zhang Y, Schyvens CG, McKenzie KU, Morris BJ, Whitworth JA. Lipopolysaccharide reverses adrenocorticotrophic hormone-induced hypertension in the rat. Hypertens Res 2003; 26(5): 427-432.
28. Schyvens CG, Cowden WB, Zhang Y, McKenzie KU, Whitworth JA. Hemodynamic effects of the nitric oxide donor DETA/NO in mice. Clin Exp Hypertens 2004; 26(6): 525-535.
29. Liu Y, Mladinov D, Pietrusz JL, Usa K, Liang M. Glucocorticoid response elements and 11-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res 2009; 81(1)):140-147.
30. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KU, et al. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J Hypertens 2003; 21(8): 1513-1518.
31. Mondo CK, Zhang Y, VdM Possamai, Miao Y, Schyvens CG, McKenzie KUS, et al. N-Acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat. Clin Exp Hypertens 2006; 28(2): 73-84.
32. Zhang Y, Miao Y, Whitworth JA. Aspirin prevents and partially reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 2007; 20 (11): 1222-1228.
33. Zhang Y, Chan MMK, Andrews MC, Mori TA, Croft KD, McKenzie KUS, et al. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 2005; 18(7): 910-916.
34. Miao Y, Zhang Y, Lim PS, Kanjanapan Y, Mori TA, Croft KD, et al. Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat. Am J Hypertens 2007; 20(3): 304-310.
35. Chin-Dusting JPF, Ahlers BA, Kaye DM, Kelly JJ, Whitworth JA. L-Arginine transport in humans with cortisol-induced hypertension. Hypertension 2003; 41(6): 1336-1340.